Chapin Davis Inc. Purchases 5,500 Shares of BlackRock Health Sciences Term Trust (NYSE:BMEZ)

Chapin Davis Inc. lifted its position in shares of BlackRock Health Sciences Term Trust (NYSE:BMEZFree Report) by 33.2% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 22,050 shares of the company’s stock after purchasing an additional 5,500 shares during the period. Chapin Davis Inc.’s holdings in BlackRock Health Sciences Term Trust were worth $361,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also added to or reduced their stakes in BMEZ. PNC Financial Services Group Inc. boosted its holdings in shares of BlackRock Health Sciences Term Trust by 22.4% during the 3rd quarter. PNC Financial Services Group Inc. now owns 25,955 shares of the company’s stock worth $374,000 after buying an additional 4,745 shares in the last quarter. LPL Financial LLC boosted its holdings in shares of BlackRock Health Sciences Term Trust by 0.5% during the 3rd quarter. LPL Financial LLC now owns 274,665 shares of the company’s stock worth $3,958,000 after buying an additional 1,231 shares in the last quarter. Alpine Global Management LLC boosted its holdings in shares of BlackRock Health Sciences Term Trust by 165.2% during the 3rd quarter. Alpine Global Management LLC now owns 74,554 shares of the company’s stock worth $1,074,000 after buying an additional 46,442 shares in the last quarter. Lazard Asset Management LLC boosted its holdings in shares of BlackRock Health Sciences Term Trust by 344.8% during the 3rd quarter. Lazard Asset Management LLC now owns 642,545 shares of the company’s stock worth $9,259,000 after buying an additional 498,079 shares in the last quarter. Finally, Almitas Capital LLC bought a new position in shares of BlackRock Health Sciences Term Trust during the 3rd quarter worth approximately $1,501,000.

BlackRock Health Sciences Term Trust Stock Up 0.3 %

Shares of NYSE:BMEZ opened at 15.40 on Tuesday. BlackRock Health Sciences Term Trust has a twelve month low of 12.93 and a twelve month high of 16.59. The stock’s 50 day moving average is 15.12 and its 200-day moving average is 15.39.

BlackRock Health Sciences Term Trust Increases Dividend

The company also recently announced a monthly dividend, which was paid on Friday, June 28th. Stockholders of record on Friday, June 14th were given a dividend of $0.179 per share. This represents a $2.15 dividend on an annualized basis and a dividend yield of 13.95%. This is a positive change from BlackRock Health Sciences Term Trust’s previous monthly dividend of $0.09. The ex-dividend date of this dividend was Friday, June 14th.

BlackRock Health Sciences Term Trust Profile

(Free Report)

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.

Featured Articles

Want to see what other hedge funds are holding BMEZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Term Trust (NYSE:BMEZFree Report).

Institutional Ownership by Quarter for BlackRock Health Sciences Term Trust (NYSE:BMEZ)

Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.